Similarly, overactivated P38 has been shown to increase tau phosphorylation and favor amyloidogenic processing of the amyloid precursor protein (APP), while inhibition of JNK by D-JNKI1 is suggested to suppress synaptic shrinkage in AD patients [149,151,152]. The gene discussed is MAPT; the disease is Alzheimer disease.